TTM Family | PRIMEAI Completes First Close of Nearly RMB 100 Million A1 Round Financing, Accelerating the Buildout of AI-Native Clinical Trial Infrastructure Jul.08.2026
TTM Capital Ranks on FOFWEEKLY's 2025 Soft Power Ranking of New Quality Productivity Investment Institutions – Top 20 in Healthcare & Life Sciences Sept.15.2025
TTM・Family | Portfolio Company Lead Healthcare Secures Nearly 100 Million CNY in Angel Round Capital Raising, Building a Tech Pioneer in AI Life Science Instruments and Bio-Manufacturing Equipment Industry Sept.15.2025
TTM Family | Tosun Pharmaceutical Completes US$40 Million Angel Round to Accelerate Pipeline Development and Support Its Growth as a Leader in Innovative Oncology Therapies Feb.03.2026
TTM·Family | ALLYRNA Completes Nearly USD 10 Million Seed Round Capital Raising, Laying a Solid Foundation for R&D in Oncology Therapy and Radiosensitizers Aug.19.2025
TTM・Family | Zenitar Secures Nearly 400 Million CNY in Series B+ Capital Raising, Focusing on Advancing Multiple Global Competitive Innovative Drugs into Pivotal Clinical Stages Aug.08.2025
